{'fraction_non_alphanumeric': 0.02395964691046658, 'fraction_numerical': 0.011349306431273645, 'mean_word_length': 5.155038759689923, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Radiation and chemoradiation therapy of patients with cancer of the lung following exploratory thoracotomy].

The results of radio- and chemoradiotherapy of 109 patients with pulmonary cancer after exploratory thoracotomy were studied. In these patients, the tumour invasion to the adjacent organs and vessels, involvement of the root of a lung and lymphatic mediastinal nodes, metastatic pleural lesion were revealed. As a result of the use of radio- and chemoradiotherapy, the tumour diminishing was documented in 48.8 and 53.2% of the cases, respectively. The adverse effects were cupped off in most patients by means of the symptomatic agents. A conclusion of the expediency to perform radio- and chemoradiotherapy in patients with pulmonary cancer after exploratory thoracotomy was made.